Abstract:Platelets are involved in liver regeneration and hepatic diseases via releasing several cytokines, including 5-hydroxytryptamine, platelet-derived growth factors and so forth. Due to splenic breakdown, a decrease in thrombopoietin production, and a capture of platelets by the liver [1], platelet count (PLT) generally reduces in cirrhotic patients. Furthermore, a PLT < 160 10/l significantly increased the risk of cirrhosis in patients with known/suspected liver disease [2]. In addition, thrombocytopenia/a low PLT was independently associated with hepatic carcinogenesis [3,4]. However, the association between PLT and prognosis of hepatocellular carcinoma (HCC) remains inconsistent and controversial. To explore the predictive significance of thrombocytopenia on survival of HCC patients who received surgical resection, we systematically searched PubMed, Embase and Web of Science until July 2014. We only included the studies whose PLT was expressed as binary variable. The primary outcomes were overall survival (OS) and recurrence-free survival (RFS) (or disease-free survival). Finally, we identified nine eligible publications, which consisted of 1434 men and 519 women (Table I). Among these, six reported hazard ratio (HR) value for OS and six studies were available to assess RFS. The cutoff value of PLT ranged from 100 to 150 ( 10/l). By pooling these studies (with adjusted HR, if available) using a random effects model, we found that preoperative thrombocytopenia was a significant predictor of short postoperative survival, with a HR value 1.51 (95% CI, 1.15–1.97, I 43.4%, p = 0.116) for OS and 1.44 (95% CI, 1.04–1.99, I 72.1%, p = 0.003) for RFS. By contrast, a significant relation was also observed between thrombocytopenia and outcome of HCC when we used a fixed effects model. Impact analysis was carried out, and it suggested that no single study could affect the results. In addition, we found no significant evidence of publication bias (a p value for OS and RFS 0.188, 0.133 in Begg’s test and 0.624, 0.201 in Egger’s test, respectively). We suggested that preoperative thrombocytopenia was an unfavorable factor for the prognosis of HCC. However, Buergy et al. [5] emphasized that thrombocytosis at the time of diagnosis was associated with a shorter survival in several solid tumors, including HCC. Shen et al. [6] suggested that patients with a preoperative PLT level ‡300 10/l had a worse OS (p = 0.020) as well as RFS (p = 0.009) compared with patients with a low level. In vitro, platelets could stimulate cell growth, migration and invasion, as well as increase AFP levels in several HCC cell lines [7]. These findings indicated that excessive platelets might induce a poor prognosis as well. Therefore, not only was thrombocytopenia a crucial predisposing factor for HCC occurrence, but it was also a helpful, readily available and inexpensive indictor to predict survival in individuals with HCC. However, more studies are needed to elucidate the exact mechanism of the relationship between PLT and HCC outcome.

Lower Mean Platelet Volume is a Risk Indicator of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.

Association of Karnofsky Performance Status with liver transplant outcomes in hepatocellular carcinoma

Relationship Between Clinicopathologic Features and Neoplasm Recurrence,prognosis in Hepatocellular Carcinoma after Liver Transplantation

Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation

Alpha-fetoprotein and 18F-FDG Standard Uptake Value Predict Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Preliminary Experience.

[Influence of Tumor Characteristics on the Outcome of Liver Transplantation among Patients with Hepatocellular Carcinoma].

Lower Mean Platelet Volume Predicts Poor Prognosis in Renal Cell Carcinoma

Mean Platelet Volume/platelet Count Ratio in Hepatocellular Carcinoma

Human leukocyte antigen-G and prognosis of liver transplantation in patients with hepatocellular carcinoma

[Association of Microvascular Invasion with Recurrence and Prognosis of Patients with Small Hepatocellular Carcinoma Undergoing Liver Transplantation].

[Liver Transplantation for Hepatocellular Carcinoma: Prognostic Analysis of 89 Cases].

Thrombocytopenia As an Inexpensive, Valuable Predictor for Survival in Patients with Hepatocellular Carcinoma.

A High Preoperative Platelet-Lymphocyte Ratio is a Negative Predictor of Survival after Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Study.

The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Blood Indices and Circulating Tumor Cells for Predicting Metastasis of Hepatocellular Carcinoma after Liver Transplantation

CD147, MMP-2, MMP-9 and MVD-CD34 Are Significant Predictors of Recurrence after Liver Transplantation in Hepatocellular Carcinoma Patients.

Preoperative alkaline phosphatase-to-platelet count ratio as a prognostic factor for hepatocellular carcinoma with microvascular invasion

Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study

Platelet-to-Lymphocyte Ratio and Large Tumor Size Predict Microvascular Invasion after Resection for Hepatocellular Carcinoma

Prognostic role of platelet lymphocyte ratio (PLR) among patients with hepatocellular carcinoma undergoing liver transplantation

Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma